Bardy Diagnostics, Inc., a Seattle, WA-based provider of ambulatory cardiac monitoring technologies and custom data solutions, raised additional growth capital from its existing equity investors.
Backers included SV Health Investors, Health Enterprise Partners, and Ascension Ventures.
The growth capital will be used to expand BardyDx’s sales force and monitoring services, advance research and development programs, and accelerate development of artificial intelligence diagnostic capabilities.
Led by Gust H. Bardy, MD, Founder and Chief Executive Officer, and Mark Handfelt, Chief Operating Officer, Bardy Diagnostics focuses on providing diagnostically-accurate and patient-friendly cardiac patch and other monitors. The company’s CAM patch is a non-invasive, P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device that is designed to improve patient compliance for men, women, and children through its lifestyle-enabling patch design. Designed to be worn by both men and women, the female-friendly, hourglass-shaped CAM patch is placed on the center of the chest, directly over the heart for optimum ECG signal collection.